Vascular gene transfer of the human inducible nitric oxide synthase: Characterization of activity and effects on myointimal hyperplasia

Molecular Medicine

Volumn 2, Issue 2, 1996, Pages 211-225

  Tzeng, Edith ^a   Shears II, Larry L ^a   Robbins, Paul D ^a   Pitt, Bruce R ^a   Geller, David A ^a   Watkins, Simon C ^a   Simmons, Richard L ^a   Billiar, Timothy R ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; EXPRESSION VECTOR; GENE EXPRESSION; GENE INDUCTION; GENE TRANSFER; HUMAN; HYPERPLASIA; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VASCULAR ENDOTHELIUM;

EID: 0029753229     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401618     Document Type: Article

References (44)

1. Ross R. (1993) The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 362: 801-809.
2. Powel JS, Clozel JP, Muller RK, et al. (1989) Inhibitors of angiotension-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186-188.
3. Simons M, Edelman ER, DeKeyser JL, Langer RS, Rosenberg RD. (1992) Antisense c-myb oligonucleotides suppress smooth muscle accumulation in vivo. Nature 359: 67-70.
4. Ohno T, Gordon D, San H, et al. (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265: 781-784.
5. Chang MW, Barr E, Seltzer J, et al. (1995) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518-522.
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84: 9265-9269.
7. Palmer RMJ, Ferrige AG, Moncada S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-527.
8. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecarvo EG, Hyman AL, Kadowitz PJ. (1981) Evidence for the inhibitory role of guanosine 3′:5′-monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955.
9. Garg UC, Hassid A. (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777.
10. Kubes P, Suzuki M, Granger DN. (1991) Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88: 4651-4655.
11. 2+-dependently converts L-arginine into an activation of soluble guanylyl cyclase. Biochem. Biophys. Res. Commun. 164: 678-685.
12. Busse R, Mülsch A. (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265: 133-136.
13. Linder L, Kiowski W, Buhler FR, Luscher TF. (1990) Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81: 1762-1767.
14. Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323: 22-27.
15. O'Donohoe MK, Murchan PM, Marks P, Feely J, Feeley TM. (1993) Endothelium-derived relaxing factor is absent in experimental in situ vein grafts. Eur. J. Vasc. Surg. 7: 144-150.
16. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. (1990) Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 336: 897-900.
17. McNamara DB, Bedi B, Aurora H, et al. (1993) L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193: 291-296.
18. Davies MG, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen PO. (1994) Reduction of experimental vein graft intimai hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 116: 557-568.
19. von der Leyen HE, Gibbons GH, Morishita R, et al. (1995) Gene therapy inhibiting neointimal vascular lesions: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. U.S.A. 92: 1137-1141.
20. Morris Jr SM, Billiar TR. (1994) New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266: E829-E839.
21. Werner-Felmayer E, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. (1990) Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J. Exp. Med. 172: 1599-1607.
22. Geller DA, Lowenstein CJ, Shapiro RA, et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90: 3491-3495.
23. Dranoff G, Jaffee EM, Lazenby A, et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine GMCSF stimulates potent, specific and long lasting antitumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90: 3539-3543.
24. Zitvogel L, Tahara H, Cai Q, et al. (1994) Construction and characterization of retroviral vectors expressing biologically-active human interleukin-12. Human Gene Ther. 5: 1493-1506.
25. Price J, Turner D, Cepko C. (1987) Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 84: 156-160.
26. Pear WS, Nolan GP, Scott ML, Baltimore D. (1993) Production of high titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90: 8392-8396.
27. Danos O, Mulligan RC. (1988) Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. U.S.A. 85: 6460-6464.
28. Danos O. (1991) Construction of retroviral packaging cell lines. In: Collins M (ed). Methods in Molecular Biology, Vol. 5: Practical Molecular Virology, Viral Vectors for Gene Expression. Humana Press, Clifton, NJ, pp. 17-27.
29. Davies P, Patton W. (1994) Peripheral and central vascular smooth muscle cells from rat lung exhibit different cytoskeletal protein profiles but similar growth factor requirements. J. Cell. Physiol. 159: 399-406.
30. Chomczynski P, Sacchi N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
31. Geller DA, Nussler AK, DiSilvio M, et al. (1993) Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90: 522-526.
32. Luss H, DiSilvio M, Litton AL, Molina y Vedia L, Nussler AK, Billiar TR. (1994) Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem. Biophys. Res. Commun. 204-2: 635-640.
33. Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
34. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. (1989) An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J. Exp. Med. 169: 1467-1472.
35. Takeshita S, Gal D, Leclerc G, et al. (1994) Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation: In vitro and in vivo findings in a rabbit model of vascular injury. J. Clin. Invest. 93: 652-661.
36. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. (1993) Macrophage nitric oxide synthase subunits: Purification, characterization, and role of prosthetic groups and substrates in modulating their association into a dimeric enzyme. J. Biol. Chem. 268: 21120-21129.
37. Tzeng E, Billiar TR, Robbins PD, Loftus M, Stuehr DJ. (1995) Expression of human inducible NO synthase in a tetrahydrobiopterin-deficient cell line: tetrahydrobiopterin promotes assembly of enzyme subunits into an active dimer. Proc. Natl. Acad. Sci. U.S.A. 92: 11771-11775.
38. Croen KD. (1993) Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex type 1 replication. J. Clin. Invest. 91: 2446-2456.
39. Hansson GK, Geng Y, Holm J, Hardhammar P, Wennmalm A, Jennische E. (1994) Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 180: 733-738.
40. Kaufman S. (1963) The structure of phenylalanine hydroxylation cofactor. Proc. Natl. Acad. Sci. U.S.A. 50: 1085-1093.
41. Nakayama DK, Geller DA, DiSilvio M, et al. (1994) Tetrahydrobiopterin synthesis and inducible nitric oxide production in pulmonary artery smooth muscle. Am. J. Physiol. 266: L455-L460.
42. Lancaster Jr JR. (1994) Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 91: 8137-8141.
43. Strauss BH, Chisholm RJ, Keeley FW, Gotleib AI, Logan RA, Armstrong PW. (1994) Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 75: 650-658.
44. Curran RD, Ferrari FK, Kispert PH, et al. (1991) Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5: 2085-2092.